Market Share of Germany Diabetes Drugs Industry
The Germany Diabetes Drugs Market is fragmented, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.
Germany Diabetes Drugs Market Leaders
Novo Nordisk A/S
Sanofi Aventis
AstraZeneca
Eli Lilly and Company
Merck
*Disclaimer: Major Players sorted in no particular order
